All Type of News
Chong Kun Dang loses in lawsuit
Chong Kun Dang Pharmaceutical lost in a rebate lawsuit the company filed against the Ministry of Health and Welfare, claiming a 20-percent slash in drug prices is unlawful.
On Friday, the Seoul Administrative Court...
Korean companies set to launch high-dose Gleevec pills
Several Korean drug makers are poised to release high-dose Gleevec tablets, according to Dasan Medichem, a local formulation company.
Dasan has worked together with the country's seven leading pharmaceutical compa...
Kombiglyze XR pills approved in Korea for treatment of type 2 diabetes in adults
Bristol-Myers Squibb (BMS) Korea announced Sunday that the Korea Food and Drug Administration approved Kombiglyze XR tablets 2.5/1000mg for the treatment of type 2 diabetes in adults, following its approval of the sam...
18 products posting over 10 billion won in first-quarter sales
Local drug makers generated 18 products surpassing 10 billion won by value during the first quarter of this year.
Yakup.com, a pharmaceutical information company, said yesterday that the top seller was Bacchus, a p...
Health insurance fee to readjust every June
The Ministry of Health and Welfare said Thursday that the scope of national health insurance (NHI) premiums will be determined at the end of June every year in an effort to reflect more accurate amount of national sub...
Doctors oppose DRG plan
The Korean Medical Association (KMA) and the government have clashed over a new medical plan, so-called DRG (Diagnosis Related Groups) plan, under which medical fees for treatment of seven diseases will be fixed and c...
Court rules against Schering Plough in patent suit
Korea’s top court on Thursday dismissed claims by Schering Plough in a patent lawsuit against two local drug firms over their generic medicine Nasonex(mometasone nasal spray), a prescription nasal spray used to treat ...
Ildong forges strategic tie-up with Pfizer Korea
Ildong Pharmaceutical said yesterday that it has established a marketing and distribution partnership with Pfizer Korea.
Under the deal, Ildong will be in charge of selling Pfizer’s six products – five anticancer ...
Cialis will benefit from new indications
The Korea Food and Drug Administration said Monday that it has approved Eli Lilly's Cialis 5 mg to treat men with symptoms of BPH alone or with both benign prostatic hyperplasia (BPH) symptoms and erectile dysfunction...
Drug makers urged to bet on expensive medicines
Soaring research costs, rampant illicit rebates and a gushing inflow of multinational drug giants following free trade pacts have come together to ignite the biggest crisis in years in Korea’s pharmaceutical industry....
